instituto Portugues de Oncologia Porto

Academic/Hospital

Also known as: Institute of Oncology of Porto, Portugal | Instituto Portugues de Oncologia, Francisco Gentil, Porto | Instituto Portugues de Oncologia Lisboa: Portugal | instituto Portugues de Oncologia Porto: Portugal

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Mar 1, 2015

Last known activity

Feb 16, 2021

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 2 trials)

Phase 2 (2 own, 0 via acquisition)

durvalumab
donor regulatory t lymphocytes

Indications

Studied for

Graft vs Host Disease

Recent trials (2)

NCT05267392Lead sponsorPhase 1/Phase 2Feb 16, 2021
NCT02385019CollaboratorPhase 1/Phase 2Mar 1, 2015

Details

Last known activity: Feb 16, 2021